EUVIMEDEUVIMED entdecken
Crossref

Tri‐Compartmental Restriction Spectrum Imaging Based on 18 F‐FDG PET / MR for Identification of Primary Benign and Malignant Lung Lesions

Xue Liu iD, Nan Meng iD, Yihang Zhou, Fangfang Fu, Jianmin Yuan, Zhe Wang, Yang Yang, Zhongyan Xiong, Chao Zou iD, Meiyun Wang

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Xue Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Zhengzhou University People's Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Lung Neoplasms, Positron-Emission Tomography, Diffusion Magnetic Resonance Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Joint Fund of Henan Province Science and Technology R&D Program, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Restriction spectrum imaging (RSI), as an advanced quantitative diffusion‐weighted magnetic resonance imaging technique, has the potential to distinguish primary benign and malignant lung lesions.

Objective

To explore how well the tri‐compartmental RSI performs in distinguishing primary benign from malignant lung lesions compared with diffusion‐weighted imaging (DWI), and to further explore whether positron emission tomography/magnetic resonance imaging (PET/MRI) can improve diagnostic efficacy. Study Type Prospective. Population 137 patients, including 108 malignant and 29 benign lesions (85 males, 52 females; average age = 60.0 ± 10.0 years). Field Strength/Sequence T2WI, T1WI, multi‐ b value DWI, MR‐based attenuation correction, and PET imaging on a 3.0 T whole‐body PET/MR system. Assessment The apparent diffusion coefficient (ADC), RSI‐derived parameters (restricted diffusion , hindered diffusion , and free diffusion ) and the maximum standardized uptake value (SUVmax) were calculated and analyzed for diagnostic efficacy individually or in combination. Statistical Tests Student's t ‐test, Mann–Whitney U test, receiver operating characteristic (ROC) curves, Delong test, Spearman's correlation analysis. P < 0.05 was considered statistically significant.

Results

The , SUVmax were significantly higher, and , ADC were significantly lower in the malignant group [0.717 ± 0.131, 9.125 (5.753, 13.058), 0.194 ± 0.099, 1.240 (0.972, 1.407)] compared to the benign group [0.504 ± 0.236, 3.390 (1.673, 6.030), 0.398 ± 0.195, 1.485 ± 0.382]. The area under the ROC curve (AUC) values ranked from highest to lowest as follows: AUC (SUVmax) > AUC () > AUC () > AUC (ADC) > AUC () (AUC = 0.819, 0.811, 0.770, 0.745, 0549). The AUC (AUC = 0.900) of the combined model of RSI with PET was significantly higher than that of either single‐modality imaging.

Conclusion

RSI‐derived parameters (, ) might help to distinguish primary benign and malignant lung lesions and the discriminatory utility of was not observed. The RSI exhibits comparable or potentially enhanced performance compared with DWI, and the combined RSI and PET model might improve diagnostic efficacy. Level of Evidence 2. Technical Efficacy Stage 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Lung NeoplasmsPositron-Emission TomographyDiffusion Magnetic Resonance ImagingHumansFemaleMaleMiddle AgedProspective StudiesAgedMultimodal ImagingROC CurveRadiopharmaceuticalsLungSensitivity and SpecificityMagnetic Resonance ImagingReproducibility of ResultsAdultDiagnosis, Differential

Stichwörter der Autor:innen

PET/MRdiffusion MRIlung lesionsrestriction spectrum imaging

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Medical Imaging, Zhengzhou University People's Hospital, Zhengzhou, China.
  • Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, China.
  • Department of Medical Imaging, Xinxiang Medical University Henan Provincial People's Hospital, Zhengzhou, China.
  • Central Research Institute, United Imaging Healthcare Group, Shanghai, China.
  • Beijing United Imaging Research Institute of Intelligent Imaging, United Imaging Healthcare Group, Beijing, China.
  • Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

ORCID-Profile: Xue Liu, Nan Meng, Chao Zou

Förderung

  • National Natural Science Foundation of China
  • Joint Fund of Henan Province Science and Technology R&D Program
  • National Key R&D Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Liu, X., Meng, N., Zhou, Y., Fu, F., Yuan, J., Wang, Z., Yang, Y., Xiong, Z., Zou, C., & Wang, M. (2025). Tri‐Compartmental Restriction Spectrum Imaging Based on 18 F‐FDG PET / MR for Identification of Primary Benign and Malignant Lung Lesions. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29438

Vancouver

Liu X, Meng N, Zhou Y, Fu F, Yuan J, Wang Z, et al. Tri‐Compartmental Restriction Spectrum Imaging Based on 18 F‐FDG PET / MR for Identification of Primary Benign and Malignant Lung Lesions. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29438

BibTeX
@article{Liu2025,
  author = {Liu, Xue and Meng, Nan and Zhou, Yihang and Fu, Fangfang and Yuan, Jianmin and Wang, Zhe and Yang, Yang and Xiong, Zhongyan and Zou, Chao and Wang, Meiyun},
  title = {Tri‐Compartmental Restriction Spectrum Imaging Based on 18 F‐FDG PET / MR for Identification of Primary Benign and Malignant Lung Lesions},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29438}
}
Kostenlos starten →